Literature DB >> 34917237

Novel Spiropiperidine Allosteric Modulators of Nicotinic Acetylcholine Receptors for Treating Central Nervous System Disorders.

Ram W Sabnis1.   

Abstract

Entities:  

Year:  2021        PMID： 34917237      PMCID： PMC8667065          DOI： 10.1021/acsmedchemlett.1c00569

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN： 1948-5875            Impact factor:   4.345


× No keyword cloud information.
  6 in total

Review 1.  Cholinergic modulation of the immune system - A novel therapeutic target for myocardial inflammation.

Authors:  Jing Lu; Weifeng Wu
Journal:  Int Immunopharmacol       Date:  2021-02-04       Impact factor: 4.932

Review 2.  Striatal cholinergic transmission. Focus on nicotinic receptors' influence in striatal circuits.

Authors:  Maxime Assous
Journal:  Eur J Neurosci       Date:  2021-02-02       Impact factor: 3.386

Review 3.  Relationships and Interactions between Ionotropic Glutamate Receptors and Nicotinic Receptors in the CNS.

Authors:  Trevor W Stone
Journal:  Neuroscience       Date:  2021-06-08       Impact factor: 3.590

Review 4.  α7 nicotinic acetylcholine receptors as therapeutic targets in schizophrenia: Update on animal and clinical studies and strategies for the future.

Authors:  Alvin V Terry; Patrick M Callahan
Journal:  Neuropharmacology       Date:  2020-03-15       Impact factor: 5.250

Review 5.  NMDA receptor-independent LTP in mammalian nervous system.

Authors:  Karim A Alkadhi
Journal:  Prog Neurobiol       Date:  2021-01-02       Impact factor: 11.685

Review 6.  Regulators of cholinergic signaling in disorders of the central nervous system.

Authors:  Katarzyna Winek; Hermona Soreq; Andreas Meisel
Journal:  J Neurochem       Date:  2021-02-26       Impact factor: 5.372
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.